Clincosm LogoSign in Get a demo

hormone sensitive prostate cancer

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Prostate Cancer, Hormone Sensitive Prostate Cancer, Chemo Effect Trial in Nanjing (Docetaxel, Rezvilutamide)

Recruiting
  • Metastatic Prostate Cancer
  • +2 more
  • Nanjing, Jiangsu, China
    Urology dpt, First Affiliated Hospital of Nanjing Medical Univer
Aug 2, 2023

Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery

Recruiting
  • Prostate Cancer
  • +6 more
  • Radiotherapy (SBRT) and/or surgery (metastasectomy)
  • +2 more
  • Leuven, Belgium
    University Hospitals Leuven
Jun 7, 2022

Hormone Sensitive Prostate Cancer Trial in Qingdao (SHR7280)

Recruiting
  • Hormone Sensitive Prostate Cancer
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
Jan 13, 2022

Prostate Cancer, Chemo Effect, Hormone Sensitive Prostate Cancer Trial (Neoadjuvant chemo combined with hormone therapy,

Not yet recruiting
  • Prostate Cancer
  • +3 more
  • Neoadjuvant chemotherapy combined with hormone therapy
  • +2 more
  • (no location specified)
Jan 4, 2020

Hormone Sensitive Prostate Cancer, Prostate Cancer, Cardiac Event Trial in Petah Tikva (Degarelix, GnRH agonist)

Unknown status
  • Hormone Sensitive Prostate Cancer
  • +2 more
  • Petah Tikva, Israel
    Rabin Medical Center - Beilinson Hospital
Nov 27, 2019